Fukushima Medical University · Department of Radiation Oncology · 准教授

Research keywordsrenal cell carcinoma・endoscopic combined intrarenal surgery・immune checkpoint inhibitors・nivolumab plus ipilimumab・immune-related adverse events・fukushima daiichi nuclear power plant

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Combination of oligo-fractionated irradiation with nivolumab can induce immune modulation in gastric cancer.2024 · Mimura K, Ogata T, Nguyen PHD, Roy S, Kared H, Yuan YC, Fehlings M, Yoshimoto Y, Yoshida D, Nakajima S, Sato H, Machida N, Yamada T, Watanabe Y, Tamaki T, Fujikawa H, Inokuchi Y, Hayase S, Hanayama H, Saze Z, Katoh H, Takahashi F, Oshima T, Goel A, Nardin A, Suzuki Y, Kono K
• Anti-PD-1 monoclonal antibody-resistant esophageal squamous cell carcinoma showing the abscopal effect: A case report with T-cell receptor/B-cell receptor repertoire analysis.2023 · Takehara Y, Mimura K, Suzuki Y, Watanabe Y, Yoshimoto Y, Saze Z, Sato H, Tamaki T, Kono K
• Disaster Resilience Reduces Radiation-Related Anxiety Among Affected People 10 Years After the Fukushima Daiichi Nuclear Power Plant Accident.2022 · Kobayashi T, Maeda M, Nakayama C, Takebayashi Y, Sato H, Setou N, Momoi M, Horikoshi N, Yasumura S, Ohto H
• Neoadjuvant Superselective Intra-Arterial Cisplatin Chemoradiotherapy Combined With Surgery in Patients With T4 Squamous Cell Carcinoma of the Maxillary Sinus.2022 · Ikeda M, Suzuki M, Matsuzuka T, Ishii S, Sato H, Murono S

• Official profile